Herbal Dispatch Inc.
Herbal Dispatch Inc. owns and operates cannabis e-commerce platforms in Canada and the United States. It provides cannabis and cannabis related products comprising dried flowers, pre-rolls, concentrates, vapes, edibles, oils and capsules, topicals, CBD, plants and seeds, and other accessories; and small-batch craft cannabis flower and a range of other product formats through its flagship cannabis… Read more
Herbal Dispatch Inc. (HA9) - Net Assets
Latest net assets as of September 2025: €1.39 Million EUR
Based on the latest financial reports, Herbal Dispatch Inc. (HA9) has net assets worth €1.39 Million EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€9.51 Million) and total liabilities (€8.12 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.39 Million |
| % of Total Assets | 14.63% |
| Annual Growth Rate | -24.62% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 14.31 |
Herbal Dispatch Inc. - Net Assets Trend (2021–2024)
This chart illustrates how Herbal Dispatch Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Herbal Dispatch Inc. (2021–2024)
The table below shows the annual net assets of Herbal Dispatch Inc. from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €2.78 Million | -34.53% |
| 2023-12-31 | €4.24 Million | -32.43% |
| 2022-12-31 | €6.28 Million | -3.18% |
| 2021-12-31 | €6.48 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Herbal Dispatch Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 945936000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €80.88 Million | 2912.94% |
| Total Equity | €2.78 Million | 100.00% |
Herbal Dispatch Inc. Competitors by Market Cap
The table below lists competitors of Herbal Dispatch Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Renforth Resources Inc
PINK:RFHRF
|
$3.75 Million |
|
Aspen Group Inc
OTCQB:ASPU
|
$3.75 Million |
|
Palram
TA:PLRM
|
$3.75 Million |
|
Fertilizantes Heringer S.A
SA:FHER3
|
$3.75 Million |
|
Hypha Labs, Inc.
PINK:FUNI
|
$3.75 Million |
|
CA Sales Holdings Ltd.
JSE:CAA
|
$3.75 Million |
|
Vision Lithium Inc
OTCQB:ABEPF
|
$3.75 Million |
|
Design Co. Ltd
KQ:227100
|
$3.74 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Herbal Dispatch Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,241,241 to 2,776,702, a change of -1,464,539 (-34.5%).
- Net loss of 2,773,049 reduced equity.
- New share issuances of 407,650 increased equity.
- Other factors increased equity by 900,860.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-2.77 Million | -99.87% |
| Share Issuances | €407.65K | +14.68% |
| Other Changes | €900.86K | +32.44% |
| Total Change | €- | -34.53% |
Book Value vs Market Value Analysis
This analysis compares Herbal Dispatch Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.12x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.25x to 1.12x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €0.15 | €0.04 | x |
| 2022-12-31 | €0.09 | €0.04 | x |
| 2023-12-31 | €0.06 | €0.04 | x |
| 2024-12-31 | €0.03 | €0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Herbal Dispatch Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -99.87%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -27.94%
- • Asset Turnover: 1.25x
- • Equity Multiplier: 2.85x
- Recent ROE (-99.87%) is below the historical average (-64.79%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -36.95% | -350.13% | 0.09x | 1.12x | €-3.04 Million |
| 2022 | -73.52% | -1447.78% | 0.04x | 1.27x | €-5.24 Million |
| 2023 | -48.84% | -43.66% | 0.58x | 1.93x | €-2.50 Million |
| 2024 | -99.87% | -27.94% | 1.25x | 2.85x | €-3.05 Million |
Industry Comparison
This section compares Herbal Dispatch Inc.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,244,379,027
- Average return on equity (ROE) among peers: -92.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Herbal Dispatch Inc. (HA9) | €1.39 Million | -36.95% | 5.83x | $3.75 Million |
| 26U (26U) | $6.75 Million | -514.32% | 1.08x | $243.78K |
| 27N0 (27N0) | $11.56 Million | -0.93% | 0.00x | $4.26K |
| China Resources Pharmaceutical Group Limited (640) | $90.18 Billion | 4.60% | 1.68x | $987.66 Million |
| CIG WIRELESS (6CW) | $27.09 Million | -110.19% | 3.19x | $77.40 Million |
| Solasia Pharma K.K (9SO) | $1.16 Billion | -167.91% | 0.18x | $35.57 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $11.70 Million |
| Akebia Therapeutics Inc (AX9) | $635.93 Million | -22.58% | 0.57x | $283.56 Million |
| Biofrontera AG (B8FK) | $-12.89 Million | 0.00% | 0.00x | $3.73 Million |
| AVALA RES (CVJ) | $91.87 Million | -27.32% | 0.11x | $113.22K |
| Deciphera Pharmaceuticals Inc (D05) | $341.69 Million | -52.37% | 0.33x | $2.11 Billion |